Cargando…

mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts

BACKGROUND: Conventional high-grade osteosarcoma is a primary malignant bone tumor, which is most prevalent in adolescence. Survival rates of osteosarcoma patients have not improved significantly in the last 25 years. Aiming to increase this survival rate, a variety of model systems are used to stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuijjer, Marieke L, Namløs, Heidi M, Hauben, Esther I, Machado, Isidro, Kresse, Stine H, Serra, Massimo, Llombart-Bosch, Antonio, Hogendoorn, Pancras CW, Meza-Zepeda, Leonardo A, Myklebost, Ola, Cleton-Jansen, Anne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193807/ https://www.ncbi.nlm.nih.gov/pubmed/21933437 http://dx.doi.org/10.1186/1755-8794-4-66

Ejemplares similares

Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
por: Namløs, Heidi M., et al.
Publicado: (2012)

Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
por: Kresse, Stine H., et al.
Publicado: (2012)

IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
por: Kuijjer, Marieke L, et al.
Publicado: (2013)

miR-486-5p expression is regulated by DNA methylation in osteosarcoma
por: Namløs, Heidi M., et al.
Publicado: (2022)

Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
por: Barøy, Tale, et al.
Publicado: (2014)

Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
por: Kuijjer, Marieke L, et al.
Publicado: (2014)

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH
por: Kresse, Stine H, et al.
Publicado: (2008)

Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples
por: Kresse, Stine H., et al.
Publicado: (2018)

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes
por: Lauvrak, S U, et al.
Publicado: (2013)

Osteosarcoma Models: From Cell Lines to Zebrafish
por: Mohseny, Alexander B., et al.
Publicado: (2012)

Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours
por: Kresse, Stine H, et al.
Publicado: (2010)

MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
por: Baranski, Zuzanna, et al.
Publicado: (2015)

Global Gene Expression Profiling of Human Osteosarcomas Reveals Metastasis-Associated Chemokine Pattern
por: Namløs, Heidi M., et al.
Publicado: (2012)

M-CGH: Analysing microarray-based CGH experiments
por: Wang, Junbai, et al.
Publicado: (2004)

MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma
por: Sarver, Aaron L, et al.
Publicado: (2013)

Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture
por: Buddingh, Emilie P, et al.
Publicado: (2015)

DNA Copy Number Changes in Human Malignant Fibrous Histiocytomas by Array Comparative Genomic Hybridisation
por: Kresse, Stine H., et al.
Publicado: (2010)

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
por: Namløs, Heidi M., et al.
Publicado: (2017)

Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential
por: Namløs, Heidi Maria, et al.
Publicado: (2023)

Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening
por: Grad, Iwona, et al.
Publicado: (2021)

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
por: Meijer, Danielle, et al.
Publicado: (2011)

Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
por: Baranski, Zuzanna, et al.
Publicado: (2015)

Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study
por: Machado, Isidro, et al.
Publicado: (2008)

Mesenchymal stem cell transformation and sarcoma genesis
por: Xiao, Wei, et al.
Publicado: (2013)

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
por: van Oosterwijk, Jolieke G, et al.
Publicado: (2012)

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
por: Schrage, Yvonne M, et al.
Publicado: (2009)

Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH
por: Kresse, Stine H, et al.
Publicado: (2005)

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019)

High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study
por: Giner, Francisco, et al.
Publicado: (2017)

Expression of the immune regulation antigen CD70 in osteosarcoma
por: Pahl, Jens HW, et al.
Publicado: (2015)

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
por: van Maldegem, Annemiek M, et al.
Publicado: (2012)

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
por: Barøy, Tale, et al.
Publicado: (2016)

Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis
por: Bühnemann, Claudia, et al.
Publicado: (2014)

An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma
por: Mosakhani, Neda, et al.
Publicado: (2012)

The clinical use of biomarkers as prognostic factors in Ewing sarcoma
por: van Maldegem, Annmeik M, et al.
Publicado: (2012)

Accurate 3-gene-signature for early diagnosis of liposarcoma progression
por: Serguienko, Anastassia, et al.
Publicado: (2020)

Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway
por: Nord, Karolin H., et al.
Publicado: (2013)

Preclinical Evaluation of Vemurafenib as Therapy for BRAF(V600E) Mutated Sarcomas
por: Gouravan, Sarina, et al.
Publicado: (2018)

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
por: McTiernan, Anne, et al.
Publicado: (2012)

Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ
por: Pahl, Jens HW, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ovl1gr23jdfgjlpa5vpufc21dn